DVLTDVLTTechnology · Software - Infrastructure

DVLT Stock Forecast: Datavault AI, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$0.13
−3.46% on the day

The 2 Wall Street analysts covering Datavault AI, Inc. hold a median 12-month price target of $2.5 — +1892.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 20 of 100 as at 13 Oct 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$123.2M
Ticker Nerd rank
20 / 100
Median analyst target
$2.50
Analysts covering
2
Revenue$6.7M+287.1% y/y
Operating income−$26.5M
Net income−$88.0M
Free cash flow−$72.8M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−16.3%
1M
−33.9%
YTD
−80.7%
1Y
−94.3%
From 52W high
−96.3%
From 52W low
0.0%
$0.13
$3.42
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

DVLT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Datavault AI, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Oct 2026
20 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
73
Growth
56
Issuance
50
Accruals
45
Quality
40
Revisions
31
Value
16
Volatility
16
Momentum
10

Size (73): Smaller than most of the companies we track.

Momentum (10): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

DVLT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on DVLT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$1.00$2.00$3.00Jan 26Apr 26Jul 26Oct 26DVLTHigh $3.00Median $2.50Low $2.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
2 Buy0 Hold0 Sell
Low $2.00Median $2.50High $3.00

The green dot is the last close — the median target sits +1892.0% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
5 Aug 2026Litchfield HillsInitiatesBuy$2.00
5 Aug 2026Litchfield HillsInitiatesBuy—
30 Mar 2026Maxim GroupMaintainsBuy$4.00 → $3.00
30 Mar 2026Maxim GroupMaintainsBuy—
5 Jan 2026Maxim GroupMaintainsBuy—
12 June 2025Maxim GroupUpgradeBuy—
6 Dec 2024Ascendiant CapitalMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. DVLT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

DVLT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, Datavault AI, Inc. returned −94.3% against +17.5% for the S&P 500, dividends included.

DVLT vs S&P 500, last 12 monthsTotal return, rebased to 100
050100150Jan 26Apr 26Jul 26Oct 26DVLTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

DVLT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

Datavault AI, Inc. (DVLT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
5.1×

Cheaper than 66% of US stocks

Price / sales
2.7×

Cheaper than 43% of US stocks

Price / book
0.5×

Cheaper than 84% of US stocks

EV / EBITDA
−2.9×

Cheaper than 76% of US stocks

Growth & margins
Revenue growth (YoY)
287.1%

Higher than 97% of US stocks

Earnings growth (YoY)
287.1%

Higher than 92% of US stocks

Gross margin
42.8%

Higher than 53% of US stocks

Operating margin
−393.9%

Higher than 8% of US stocks

Net margin
77.8%

Higher than 98% of US stocks

Returns & dividend
Return on equity
−108.4%

Higher than 12% of US stocks

Return on assets
−21.2%

Higher than 19% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Datavault AI, Inc. (DVLT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Datavault AI, Inc. has a market value of $123.2M and an enterprise value of $131.5M.

  • Revenue in the twelve months to 30 June 2026: $46.9M. The latest quarter grew 287.1% year on year.

  • Net income over the same four quarters: −$173.5M, a −370.2% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$93.0M.

  • Shares outstanding: 855.6M.

  • Trailing P/E: 5.1×; forward P/E: 1.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Datavault AI, Inc. employs 193 people — $243K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Oct 2026

Data provided by Twelve Data

Peers

DVLT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSoftware - Infrastructure
CompanyMarket capTKN rank
DVLTDatavault AI, Inc.$123.2M
20
QMLSQumulusAI, Inc.$134.1M
2
SKYASkyAI, Inc.$110.5M
11
AGPUAxe Compute, Inc.$110.0M
22
TPTicketplus Ltd.$106.3M
1
TCXTucows, Inc.$105.9M
36
AIBAIB Data Centers, Inc.$98.8M
1

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Datavault AI, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest DVLT news & analysis

DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform

Accesswire · 14 Oct 2026neutral

DataMeds AI announced an exclusive U.S. direct-to-consumer license, revenue-sharing and marketing agreement with REBOOT Health AI for its GLP-1 care management platform. The companies plan to tailor it for integration into the Health Lives Here app as a subscription offering.

Why it matters — The announcement concerns DataMeds AI and its planned app integration, with no stated connection to Datavault AI (DVLT).

DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division

Accesswire · 13 Oct 2026neutral

DataMeds AI said it has implemented cost-control measures, mainly by reducing corporate management positions, and refocused remaining workforce spending on commercializing ChemoFx as a diagnostic lab test. The initial focus is gynecologic cancers, with outreach to hospital systems, HMOs, GPOs and cancer centers.

Why it matters — The update concerns DataMeds AI rather than Datavault AI, so it provides no direct company-specific news about DVLT.

DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers

Accesswire · 12 Oct 2026neutral

DataMeds AI announced that its recently acquired subsidiary Helomics received a Medicaid coverage determination for the ChemoFx assay in gynecologic cancers, with Humana adding the assay to its Medicaid Pharmacogenomics Testing coverage policy.

Why it matters — The coverage policy update concerns a subsidiary of DataMeds AI and its ChemoFx assay; the excerpt does not describe any connection to DVLT.

FAQ

Frequently asked questions about DVLT stock

What is the DVLT stock price forecast for 2026-2027?

The 2 Wall Street analysts covering Datavault AI, Inc. have a median 12-month price target of $2.5, with estimates ranging from $2 to $3. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is DVLT stock a buy right now?

Of the 2 analysts covering Datavault AI, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Datavault AI, Inc. 20 out of 100 across roughly 4,600 US stocks as at 13 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank DVLT?

As at 13 Oct 2026, Datavault AI, Inc. ranks 20 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (73 of 100).

Will DVLT stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +1892.0% from the last close, and Ticker Nerd's factor model ranks Datavault AI, Inc. 20 out of 100 as at 13 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the DVLT stock forecast for 2030?

No analyst covering Datavault AI, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for DVLT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2 to $3 over the next 12 months.

How has DVLT stock performed over the past year?

Datavault AI, Inc. returned -94.3% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Datavault AI, Inc. do?

Datavault AI Inc. Common Stock is the equity of Datavault AI Inc., a data sciences technology company focused on secure data management, valuation, and monetization.

What is the latest news on DVLT?

The most recent item we track (Accesswire, 14 Oct 2026): "DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform". DataMeds AI announced an exclusive U.S. direct-to-consumer license, revenue-sharing and marketing agreement with REBOOT Health AI for its GLP-1 care management platform. The companies plan to tailor it for integration into the Health Lives Here app as a subscription offering.

Company

About Datavault AI, Inc.

Datavault AI Inc. Common Stock is the equity of Datavault AI Inc., a data sciences technology company focused on secure data management, valuation, and monetization. The company provides cloud-based platforms and software tools that combine artificial intelligence, high-performance computing, and Web 3.0 capabilities to support data-driven applications. Its offerings include data management and monetization solutions, AI-driven agents, tokenization-related technologies, and secure digital credentialing services. Datavault AI also develops acoustic science and wireless audio technologies used for spatial and multichannel sound transmission, data-over-sound communications, and related licensing applications. The company serves a range of industries, including healthcare, fintech, education, energy, real estate, sports and entertainment, automotive, and enterprise technology, positioning it as a diversified platform provider in the digital data and audio technology markets.

CEO Mr. Nathaniel T. Bradley · 193 employees · United States · https://datavaultsite.com